Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study
- PMID: 24190934
- DOI: 10.1161/CIRCULATIONAHA.113.003215
Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study
Abstract
Background: Hypertensive disorders of pregnancy are a major contributor to death and disability for pregnant women and their infants. The diagnosis of preeclampsia by using blood pressure and proteinuria is of limited use because they are tertiary, downstream features of the disease. Placental growth factor (PlGF) is an angiogenic factor, a secondary marker of associated placental dysfunction in preeclampsia, with known low plasma concentrations in the disease.
Methods and results: In a prospective multicenter study, we studied the diagnostic accuracy of low plasma PlGF concentration (<5th centile for gestation, Alere Triage assay) in women presenting with suspected preeclampsia between 20 and 35 weeks' gestation (and up to 41 weeks' gestation as a secondary analysis). The outcome was delivery for confirmed preeclampsia within 14 days. Of 625 women, 346 (55%) developed confirmed preeclampsia. In 287 women enrolled before 35 weeks' gestation, PlGF <5th centile had high sensitivity (0.96; 95% confidence interval, 0.89-0.99) and negative predictive value (0.98; 0.93-0.995) for preeclampsia within 14 days; specificity was lower (0.55; 0.48-0.61). Area under the receiver operating characteristic curve for low PlGF (0.87, standard error 0.03) for predicting preeclampsia within 14 days was greater than all other commonly used tests, singly or in combination (range, 0.58-0.76), in women presenting with suspected preeclampsia (P<0.001 for all comparisons).
Conclusions: In women presenting before 35 weeks' gestation with suspected preeclampsia, low PlGF has high sensitivity and negative predictive value for preeclampsia within 14 days, is better than other currently used tests, and presents an innovative adjunct to management of such women.
Keywords: angiogenesis inducers; diagnosis; hypertension; pregnancy.
Similar articles
-
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.N Engl J Med. 2016 Jan 7;374(1):13-22. doi: 10.1056/NEJMoa1414838. N Engl J Med. 2016. PMID: 26735990
-
Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study.Am J Obstet Gynecol. 2020 Mar;222(3):259.e1-259.e11. doi: 10.1016/j.ajog.2019.09.003. Epub 2019 Sep 10. Am J Obstet Gynecol. 2020. PMID: 31518550
-
Diagnostic accuracy of repeat placental growth factor measurements in women with suspected preeclampsia: A case series study.Acta Obstet Gynecol Scand. 2020 Aug;99(8):994-1002. doi: 10.1111/aogs.13818. Epub 2020 Feb 29. Acta Obstet Gynecol Scand. 2020. PMID: 32017014 Free PMC article.
-
Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.Hypertension. 2020 Apr;75(4):918-926. doi: 10.1161/HYPERTENSIONAHA.119.13763. Epub 2020 Feb 17. Hypertension. 2020. PMID: 32063058 Free PMC article. Review.
-
Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.Health Technol Assess. 2016 Nov;20(87):1-160. doi: 10.3310/hta20870. Health Technol Assess. 2016. PMID: 27918253 Free PMC article. Review.
Cited by
-
Maternal Placental Growth Factor (PlGF) levels, sonographic placental parameters, and outcomes of IVF pregnancies with and without embryo trophectoderm biopsy.J Assist Reprod Genet. 2024 Jul 23. doi: 10.1007/s10815-024-03193-8. Online ahead of print. J Assist Reprod Genet. 2024. PMID: 39042339
-
Circulating extracellular vesicular microRNA signatures in early gestation show an association with subsequent clinical features of pre-eclampsia.Sci Rep. 2024 Jul 22;14(1):16770. doi: 10.1038/s41598-024-64057-w. Sci Rep. 2024. PMID: 39039088 Free PMC article.
-
Alleviation of preeclampsia-like symptoms through PlGF and eNOS regulation by hypoxia- and NF-κB-responsive miR-214-3p deletion.Exp Mol Med. 2024 Jun;56(6):1388-1400. doi: 10.1038/s12276-024-01237-8. Epub 2024 Jun 3. Exp Mol Med. 2024. PMID: 38825645 Free PMC article.
-
Predicting Time to Delivery in Hypertensive Disorders: Assessing PlGF and sFlt-1 with the Novel Parameter 'Mtp-Multiples of a Normal Term Placenta'.J Clin Med. 2024 Mar 25;13(7):1899. doi: 10.3390/jcm13071899. J Clin Med. 2024. PMID: 38610664 Free PMC article.
-
The sFlt-1/PlGF Ratio at 12, 24, and 32 Weeks Gestation in Twin Pregnancies as a Predictor of Placental Dysfunction.J Clin Med. 2024 Mar 20;13(6):1784. doi: 10.3390/jcm13061784. J Clin Med. 2024. PMID: 38542007 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical